PDE10A expression correlates with lung cancer prognosis, and its pharmacological inhibition suppresses growth of NSCLC cell lines 15, so it seems a plausible candidate gene for lung cancer risk. The gene discussed is PDE10A; the disease is non-small cell lung carcinoma.